XNAS · EVGN
-3.48% · -$0.0100 · Vol 88.3K
Market closed · last close 4:00 PM ET · price as of 17:49:14 ET
EVOGENE LTD.

EVOGENE LTD.

$0.3963
Card
Relationship Map

Follow $EVGN

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $EVGN by email

Veridion Score

BETAMEDIUM CONF · 5 of 6 factors measuredMethodology
Sentiment absence reason unknown
EVGN
EVOGENE LTD.
Thu Oct 8 · market closed · Markets closed · resumes Fri 9:30 ET
Lower range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

38/ 100
Veridion Score
Lower range · MEDIUM confidence · 5 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Confidence: MEDIUM · 5 of 6 factors measured · Thu Oct 8 · market closed · Markets closed · resumes Fri 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is EVGN moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading EVGN catalysts
About EVOGENE LTD.
Listed since
2008
Employees
52
Country
US

Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the industrial segment, followed by Agriculture.

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$0.3926
Day high
$0.4085
Day low
$0.3830
Previous close
$0.4106
52W high
$1.38
-71.28% from high
52W low
$0.3800
2% of range
Market cap
$6.5M
Beta
1.95
Shares out
15.8M
Volume
88.3K
0.03× rel vol
Avg volume
2.6M
VWAP
$0.3910
Price history computed in-house
1W
-6.75%
1M
-21.06%
3M
-22.60%
1Y
-70.43%
YTD
-63.97%
SMA 50 $0.5194 · below
SMA 200 $0.7191 · below
52W position 2%

EVGN overview

Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file
Loading financial statements
Loading EVGN Form 4 filings
Public disclosures

Congress activity in EVGN

No receipt-qualified filings found.

Federal contracts

EVGN contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for EVGN in this window.
Lobbying spend

EVGN lobbying filings, year to date.

Registered lobbying filings matched to EVOGENE LTD..

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for EVGN in this window.
Loading news for EVGN
Analyst ratings
Sovereign unlock shows live analyst consensus for EVGN.
Options
Options data is temporarily unavailable. Changing your plan will not restore the upstream feed.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.